USPatentGranted
S1

Polymerase chain reaction instrument

Granted 28 Apr 2015 · 2 office actions

Current assignee: Life Technologies Corporation · originally Thermo Fisher Scientific

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Laurence Trigg, Lance Hussey, Greg Lucier, Toshihiro Aya +3 · Examiner: Wan Laymon · AU 2916 · TC 2900

Application
29/461,238
filed 19 Jul 2013
Publication
Not published
not published
Patent· this page
US D728125
granted 28 Apr 2015

Life of the patent

6 dated events
⤢ drag to zoom20142016201820202022202420262028203020322034ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Description

1 parts
›FIG. 1 is a front perspective view of…

FIG. 1 is a front perspective view of a polymerase chain reaction instrument.

FIG. 2 is a perspective view of the polymerase chain reaction instrument shown in FIG. 1 .

FIG. 3 is a front view of the polymerase chain reaction instrument shown in FIG. 1 .

FIG. 4 is a back view of the polymerase chain reaction instrument shown in FIG. 1 .

FIG. 5 is a side view of the polymerase chain reaction instrument shown in FIG. 1 .

FIG. 6 is a side view of the polymerase chain reaction instrument shown in FIG. 1 .

FIG. 7 is a top view of the polymerase chain reaction instrument shown in FIG. 1 ; and,

FIG. 8 is a bottom view of the polymerase chain reaction instrument shown in FIG. 1 .

Portions of the polymerase chain reaction instrument shown in broken lines form no part of the claimed design. The evenly dashed broken lines in the drawings illustrate the portions of the design that form no part of the claim. The dot-dot-dash broken lines in the drawings define the bounds of the claim and form no part thereof.

the grant prints no section headings; every part label below is ours, taken from that part's own first words

Claims

1 · 1 independent · depth 1
1 granted claims

Classifications

2 codes
USPC · US Patent Classification
D24/232D24/216

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJul 2013Oct 2013Jan 2014Apr 2014Jul 2014Oct 2014Jan 2015Apr 2015USPTOApplicantNon-final rejectionResponse after non-final
USPTOApplicanthover for detail · click to open
Pendency
1.8 y
648 days filing → grant
Office actions
1
non-final + final
Responses
2
no RCE
Examiner
Wan Laymon
art unit 2916 · TC 2900
Citations: 14 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock